Corsi Taylor, Ciaramella Michael A, Palte Nadia K, Carlson John P, Rahimi Saum A, Beckerman William E
Rutgers Robert Wood Johnson Medical School, Rutgers University, Piscataway, NJ.
Division of Vascular Surgery and Endovascular Therapy, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ.
J Vasc Surg. 2022 Dec;76(6):1494-1501.e1. doi: 10.1016/j.jvs.2022.05.011. Epub 2022 Jun 12.
Although sex differences in endovascular abdominal aortic aneurysm repair (EVAR) outcomes have been increasingly reported, the determination of contributing factors has not reached a consensus. We investigated the disparities in sex-specific outcomes after elective EVAR at our institution and evaluated the factors that might predispose women to increased morbidity and mortality.
We performed a retrospective medical record review of all patients who had undergone elective EVAR from 2011 to 2020 at a suburban tertiary care center. The primary outcomes were 5-year survival and freedom from reintervention. The Fisher exact test, t tests, and Kaplan-Meier analysis using the rank-log test were used to investigate the associations between sex and outcomes. A multivariable Cox proportional hazard model controlling for age and common comorbidities evaluated the effect of sex on survival and freedom from reintervention.
A total of 273 patients had undergone elective EVAR during the study period, including 68 women (25%) and 205 men (75%). The women were older on average than were than the men (76 years vs 73 years; P ≤ .01) and were more likely to have chronic obstructive pulmonary disease (38% vs 23%; P = .01), require home oxygen therapy (9% vs 2%; P = .04), or dialysis preoperatively (4% vs 0%; P = .02). The distribution of other common vascular comorbidities was similar between the sexes. The 30-day readmission rate was greater for the women than for the men (18% vs 8%; P = .02). The women had had significantly lower survival at 5 years (48% ± 7.9% vs 65% ± 4.3%; P < .01) and significantly lower 1-year (women, 89% ± 4.1%; vs men, 94% ± 1.7%; P = .01) and 5-year (women, 69% ± 8.9%; vs men, 84% ± 3.3%; P = .02) freedom from reintervention. On multivariable analysis, female sex (hazard ratio [HR], 1.8; 95% confidence interval [CI], 1.1-2.9), congestive heart failure (HR, 2.2; 95% CI, 1.2-3.9), and older age (HR, 1.1; 95% CI, 1.0-1.1) were associated with 5-year mortality. Female sex remained as the only variable with a statistically significant association with 5-year reintervention (HR, 2.4; 95% CI, 1.1-4.9).
Female sex was associated with decreased 5-year survival and increased 1- and 5-year reintervention after elective EVAR. Data from our institution suggest that factors beyond patient age and baseline health risk likely contribute to greater surgical morbidity and mortality for women after elective EVAR.
尽管血管内腹主动脉瘤修复术(EVAR)结局的性别差异报道日益增多,但对促成因素的判定尚未达成共识。我们调查了我院择期EVAR术后特定性别的结局差异,并评估了可能使女性发病和死亡风险增加的因素。
我们对2011年至2020年在一家郊区三级医疗中心接受择期EVAR的所有患者进行了回顾性病历审查。主要结局为5年生存率和无需再次干预。采用Fisher精确检验、t检验以及使用秩和检验的Kaplan-Meier分析来研究性别与结局之间的关联。一个控制年龄和常见合并症的多变量Cox比例风险模型评估了性别对生存和无需再次干预的影响。
在研究期间,共有273例患者接受了择期EVAR,其中68例为女性(25%),205例为男性(75%)。女性的平均年龄高于男性(76岁对73岁;P≤0.01),且更有可能患有慢性阻塞性肺疾病(38%对23%;P = 0.01)、术前需要家庭氧疗(9%对2%;P = 0.04)或透析(4%对0%;P = 0.02)。其他常见血管合并症在两性之间的分布相似。女性的30天再入院率高于男性(18%对8%;P = 0.02)。女性的5年生存率显著较低(48%±7.9%对65%±4.3%;P < 0.01),1年(女性为89%±4.1%;男性为94%±1.7%;P = 0.01)和5年(女性为69%±8.9%;男性为84%±3.3%;P = 0.02)无需再次干预的比例也显著较低。多变量分析显示,女性性别(风险比[HR],1.8;95%置信区间[CI],1.1 - 2.9)、充血性心力衰竭(HR,2.2;95% CI,1.2 - 3.9)和高龄(HR,1.1;95% CI,1.0 - 1.1)与5年死亡率相关。女性性别仍然是与5年再次干预有统计学显著关联的唯一变量(HR,2.4;95% CI,1.1 - 4.9)。
女性性别与择期EVAR术后5年生存率降低以及1年和5年再次干预增加相关。我院的数据表明,除患者年龄和基线健康风险外的因素可能导致女性在择期EVAR术后手术发病率和死亡率更高。